Pages that link to "Q34253607"
Jump to navigation
Jump to search
The following pages link to Oral contraceptives and the risk of venous thrombosis (Q34253607):
Displaying 50 items.
- Observational research, randomised trials, and two views of medical science (Q21144655) (← links)
- Combined oral contraceptives: venous thrombosis (Q24198113) (← links)
- Combined oral contraceptives: venous thrombosis (Q24202769) (← links)
- Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis (Q24624180) (← links)
- FNH-like nodules: Possible precursor lesions in patients with focal nodular hyperplasia (FNH) (Q24791036) (← links)
- Association of adenoma and focal nodular hyperplasia: experience of a single French academic center (Q24802860) (← links)
- Causes of venous thrombosis (Q28080150) (← links)
- Novel contraceptive targets to inhibit ovulation: the prostaglandin E2 pathway (Q28083349) (← links)
- Activation of innate immunity in patients with venous thrombosis: the Leiden Thrombophilia Study (Q28168368) (← links)
- Third generation oral contraceptives and risk of venous thrombosis: meta-analysis (Q28344562) (← links)
- Synergistic effects of hypofibrinolysis and genetic and acquired risk factors on the risk of a first venous thrombosis (Q28754730) (← links)
- Varicose vein trauma: a risk for pulmonary embolism (Q33165033) (← links)
- Drug-induced hematologic syndromes (Q33387312) (← links)
- Living near major traffic roads and risk of deep vein thrombosis (Q33955783) (← links)
- Deep vein thrombosis: a clinical review (Q34144439) (← links)
- The mechanisms of thrombotic risk induced by hormone replacement therapy (Q34421664) (← links)
- Thrombin generation profiles in deep venous thrombosis (Q34469944) (← links)
- Oral contraceptives: an update on health benefits and risks. (Q34476733) (← links)
- The phenomenon known as acquired activated protein C resistance (Q34530144) (← links)
- Diane-35 (cyproterone acetate): safety concerns (Q34536900) (← links)
- Drospirenone-containing oral contraceptive pills and the risk of venous and arterial thrombosis: a systematic review. (Q34636421) (← links)
- Evidence-based approach to thrombophilia testing (Q34663749) (← links)
- Oral contraceptives and venous thromboembolism: which are the safest preparations available? (Q34743953) (← links)
- Tentative guidelines and practical suggestions to avoid venous thromboembolism during oral contraceptive therapy (Q34743964) (← links)
- Oral contraception and the risk of thromboembolism: what does it mean to clinicians and their patients? (Q34966977) (← links)
- Antipsychotic-induced venous thromboembolism: a review of the evidence (Q34969681) (← links)
- Endovascular management of venous thrombotic diseases of the upper torso and extremities. (Q34979126) (← links)
- Exposure to particulate air pollution and risk of deep vein thrombosis (Q34979338) (← links)
- Laboratory thrombophilias and venous thromboembolism (Q34981644) (← links)
- Effective contraceptive counseling with adolescents in a nurse-based setting (Q35007958) (← links)
- Thromboembolic diseases of childhood (Q35029562) (← links)
- Hereditary and acquired defects in the fibrinolytic system associated with thrombosis (Q35081846) (← links)
- Clinical and laboratory evaluation of thrombophilia (Q35103077) (← links)
- Delay in diagnosis of cerebral venous and sinus thrombosis: successful use of mechanical thrombectomy and thrombolysis. (Q35110384) (← links)
- Hormonal birth control and pregnancy: a comparative analysis of thromboembolic risk (Q35139270) (← links)
- Thrombophilias and gynaecology (Q35145570) (← links)
- Hypercoagulable state testing and malignancy screening following venous thromboembolic events (Q35179215) (← links)
- Sinus sigmoideus thrombosis secondary to graves' disease: a case description (Q35545645) (← links)
- Mesenteric vein thrombosis associated with intravaginal contraceptives: a case report and review of the literature. (Q35584010) (← links)
- Thrombophilia and stroke (Q35610110) (← links)
- Postpartum mood disorders: a review of clinical and epidemiological factors (Q35619341) (← links)
- Higher risk of venous thrombosis associated with drospirenone-containing oral contraceptives: a population-based cohort study. (Q35664040) (← links)
- Contraception in Canada: a review of method choices, characteristics, adherence and approaches to counselling (Q35688513) (← links)
- Hyperhomocysteinemia and other thrombophilic risk factors in 26 patients with cerebral venous thrombosis. (Q35788910) (← links)
- Clinical risk factors for venous thromboembolus in users of the combined oral contraceptive pill (Q35803802) (← links)
- Iliac vein compression syndrome in an active and healthy young female (Q35808433) (← links)
- Deep vein thrombosis and pulmonary embolism reported in the Prescription Event Monitoring Study of Yasmin (Q35827099) (← links)
- Hormones and pregnancy: thromboembolic risks for women (Q35852845) (← links)
- Bilateral Spontaneous Perirenal Hemorrhage due to Initial Presentation of Polyarteritis Nodosa (Q36059548) (← links)
- New insights into the mechanisms of venous thrombosis (Q36068279) (← links)